Literature DB >> 16331324

Study on substrate specificity at subsites for severe acute respiratory syndrome coronavirus 3CL protease.

Yu-Fei Shan1, Gen-Jun Xu.   

Abstract

Autocleavage assay and peptide-based cleavage assay were used to study the substrate specificity of 3CL protease from the severe acute respiratory syndrome coronavirus. It was found that the recognition between the enzyme and its substrates involved many positions in the substrate, at least including residues from P4 to P2'. The deletion of either P4 or P2' residue in the substrate would decrease its cleavage efficiency dramatically. In contrast to the previous suggestion that only small residues in substrate could be accommodated to the S1' subsite, we have found that bulky residues such as Tyr and Trp were also acceptable. In addition, based on both peptide-based assay and autocleavage assay, Ile at the P1' position could not be hydrolyzed, but the mutant L27A could hydrolyze the Ile peptide fragment. It suggested that there was a stereo hindrance between the S1' subsite and the side chain of Ile in the substrate. All 20 amino acids except Pro could be the residue at the P2' position in the substrate, but the cleavage efficiencies were clearly different. The specificity information of the enzyme is helpful for potent anti-virus inhibitor design and useful for other coronavirus studies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16331324      PMCID: PMC7109883          DOI: 10.1111/j.1745-7270.2005.00114.x

Source DB:  PubMed          Journal:  Acta Biochim Biophys Sin (Shanghai)        ISSN: 1672-9145            Impact factor:   3.848


  18 in total

1.  Virology. The SARS coronavirus: a postgenomic era.

Authors:  Kathryn V Holmes; Luis Enjuanes
Journal:  Science       Date:  2003-05-30       Impact factor: 47.728

Review 2.  Proteolytic processing of picornaviral polyprotein.

Authors:  A C Palmenberg
Journal:  Annu Rev Microbiol       Date:  1990       Impact factor: 15.500

3.  Conservation of substrate specificities among coronavirus main proteases.

Authors:  Annette Hegyi; John Ziebuhr
Journal:  J Gen Virol       Date:  2002-03       Impact factor: 3.891

4.  Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs.

Authors:  Kanchan Anand; John Ziebuhr; Parvesh Wadhwani; Jeroen R Mesters; Rolf Hilgenfeld
Journal:  Science       Date:  2003-05-13       Impact factor: 47.728

5.  Biosynthesis, purification, and characterization of the human coronavirus 229E 3C-like proteinase.

Authors:  J Ziebuhr; G Heusipp; S G Siddell
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

6.  The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor.

Authors:  Haitao Yang; Maojun Yang; Yi Ding; Yiwei Liu; Zhiyong Lou; Zhe Zhou; Lei Sun; Lijuan Mo; Sheng Ye; Hai Pang; George F Gao; Kanchan Anand; Mark Bartlam; Rolf Hilgenfeld; Zihe Rao
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-29       Impact factor: 11.205

7.  Critical assessment of important regions in the subunit association and catalytic action of the severe acute respiratory syndrome coronavirus main protease.

Authors:  Wen-Chi Hsu; Hui-Chuan Chang; Chi-Yuan Chou; Pui-Jen Tsai; Pei-In Lin; Gu-Gang Chang
Journal:  J Biol Chem       Date:  2005-04-14       Impact factor: 5.157

8.  Structure of coronavirus main proteinase reveals combination of a chymotrypsin fold with an extra alpha-helical domain.

Authors:  Kanchan Anand; Gottfried J Palm; Jeroen R Mesters; Stuart G Siddell; John Ziebuhr; Rolf Hilgenfeld
Journal:  EMBO J       Date:  2002-07-01       Impact factor: 11.598

9.  Dissection study on the severe acute respiratory syndrome 3C-like protease reveals the critical role of the extra domain in dimerization of the enzyme: defining the extra domain as a new target for design of highly specific protease inhibitors.

Authors:  Jiahai Shi; Zheng Wei; Jianxing Song
Journal:  J Biol Chem       Date:  2004-03-22       Impact factor: 5.157

10.  Biosynthesis, purification, and substrate specificity of severe acute respiratory syndrome coronavirus 3C-like proteinase.

Authors:  Keqiang Fan; Ping Wei; Qian Feng; Sidi Chen; Changkang Huang; Liang Ma; Bing Lai; Jianfeng Pei; Ying Liu; Jianguo Chen; Luhua Lai
Journal:  J Biol Chem       Date:  2003-10-15       Impact factor: 5.157

View more
  6 in total

1.  A Charge-Switchable Zwitterionic Peptide for Rapid Detection of SARS-CoV-2 Main Protease.

Authors:  Zhicheng Jin; Yash Mantri; Maurice Retout; Yong Cheng; Jiajing Zhou; Alec Jorns; Pavla Fajtova; Wonjun Yim; Colman Moore; Ming Xu; Matthew N Creyer; Raina M Borum; Jingcheng Zhou; Zhuohong Wu; Tengyu He; William F Penny; Anthony J O'Donoghue; Jesse V Jokerst
Journal:  Angew Chem Int Ed Engl       Date:  2022-01-14       Impact factor: 15.336

Review 2.  Atlas of coronavirus replicase structure.

Authors:  Benjamin W Neuman; Peter Chamberlain; Fern Bowden; Jeremiah Joseph
Journal:  Virus Res       Date:  2013-12-16       Impact factor: 3.303

3.  Repurposing of HIV/HCV protease inhibitors against SARS-CoV-2 3CLpro.

Authors:  Ling Ma; Quanjie Li; Yongli Xie; Dongrong Yi; Saisai Guo; Fei Guo; Jing Wang; Long Yang; Shan Cen
Journal:  Antiviral Res       Date:  2022-09-23       Impact factor: 10.103

4.  Label-free Sensing of Main Protease Activity of SARS-CoV-2 with an Aerolysin Nanopore.

Authors:  Xin Zhou; Ruping Tang; Yusen Li; Shusheng Zhang; Dongmei Xi
Journal:  Chem Asian J       Date:  2022-08-27

5.  A computational analysis of SARS cysteine proteinase-octapeptide substrate interaction: implication for structure and active site binding mechanism.

Authors:  Krongsakda Phakthanakanok; Khanok Ratanakhanokchai; Khin Lay Kyu; Pornthep Sompornpisut; Aaron Watts; Surapong Pinitglang
Journal:  BMC Bioinformatics       Date:  2009-01-30       Impact factor: 3.169

6.  Molecular docking identifies the binding of 3-chloropyridine moieties specifically to the S1 pocket of SARS-CoV Mpro.

Authors:  Chunying Niu; Jiang Yin; Jianmin Zhang; John C Vederas; Michael N G James
Journal:  Bioorg Med Chem       Date:  2007-09-22       Impact factor: 3.641

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.